BHVN - Biohaven Pharmaceutical ASLAN Pharmaceuticals among major healthcare premarket losers' pack
ASLAN Pharmaceuticals (NASDAQ:ASLN) -34% despite 'positive' ASLAN004 data in atopic dermatitis. Sentage Holdings (NASDAQ:SNTG) -15%. ReWalk Robotics (NASDAQ:RWLK) -14% on $32.5M equity offering priced at premium to market. ZIVO Bioscience (NASDAQ:ZIVO) -10%. Unique Fabricating (NYSE:UFAB) -8%. Capricor Therapeutics (NASDAQ:CAPR) -8%. Ensysce Biosciences (NASDAQ:ENSC) -7% on $15M convertible note financing. Huaneng Power International (NYSE:HNP) -6%. Biohaven Pharmaceutical Holding (NYSE:BHVN) -6% after verdiperstat multiple system atrophy trial data. Elite Education Group International (NASDAQ:EEIQ) -6%.
For further details see:
Biohaven Pharmaceutical, ASLAN Pharmaceuticals among major healthcare premarket losers' pack